Skip to content

MINDEP

There is a growing body of evidence suggesting that inflammation of the brain and central nervous system is linked to multiple mental health issues, including major depressive disorder (MDD). The purpose of this study is to see if adding a course of anti-inflammatory medication (minocycline) or a placebo (sugar pill) alongside a current course of antidepressant treatment (SSRI medications) can help to reduce depressive symptoms in MDD that has not responded treatment with antidepressants alone.

Details:

We are looking for:

  • Male or Female aged 25-60
  • Current diagnosis of Major Depressive Disorder
  • Are currently taking an antidepressant medication for at least 6 weeks but have still not experienced an improvement in symptoms.
  • Must not have a known diagnosis of bipolar disorder, psychosis or current substance abuse.

Location:

  • London

Expenses:

£10 for screening and £20 for subsequent visits, with an additional £10 per visit for transport.

Contact information:

Contact Giulia Lombardo for more information: 

Email: neuroimmunology@kcl.ac.uk

Phone: 0207 848 5420

or visit the study website:

https://www.callforparticipants.com/study/A7SV0/minocycline-and-depression-mindep-study 

 

Subscribe to our newsletter. Get the latest news on mental health.

© MQ: Transforming mental health 2016 | Registered charity in England / Wales: 1139916 & Scotland: SC046075 | Company number: 7406055